Overview of the risk factors, prevention and management of SARS-COV-2
This thesis report is submitted in partial fulfillment of the requirement for the degree of Master of Science in Biotechnology, 2020.
Huvudupphovsman: | Mustafa, Nashrah |
---|---|
Övriga upphovsmän: | Hossain, Mahboob |
Materialtyp: | Lärdomsprov |
Språk: | en_US |
Publicerad: |
Brac University
2021
|
Ämnen: | |
Länkar: | http://hdl.handle.net/10361/14501 |
Liknande verk
-
In-silico based vaccine development: targeting nucleocapsid protein of SARS-CoV-2.
av: Iva, Yesmine Akter
Publicerad: (2022) -
Detection of genetic diversity of SARS-CoV-2 in wastewater to monitor COVID-19 transmission
av: Sarwar, Subyeta Binte
Publicerad: (2024) -
An in silico Method to developing an epitope-based peptide vaccination against SARS-CoV-2's Envelope Protein (E)
av: Intesar, Mohammad Nafees
Publicerad: (2023) -
Omicron, delta, and beta, deadliest among SARS-CoV-2 variants: an in silico analysis
av: Bosu, Sagar
Publicerad: (2023) -
Wave-wise comparison of COVID 19 based on SARS-CoV-2 Variants of Concern (VOCs) in Bangladesh, India, Sri Lanka, Pakistan, Nepal and the probable reasons behind the less devastating effects of Delta variant in Bangladesh: a review
av: Hasan, Mahfuzul, et al.
Publicerad: (2022)